1. Signaling Pathways
  2. Immunology/Inflammation
  3. Interleukin Related
  4. IL-33 Isoform
  5. IL-33 Inhibitor

IL-33 Inhibitor

IL-33 Inhibitor (1):

Cat. No. Product Name Effect Purity
  • HY-P99444
    Astegolimab
    Inhibitor
    Astegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research.